HUTCHMED (China) Ltd: Form 20-F for the period ended Dec 31, 2018
Filed with the SEC on Mar 11, 2019 and accepted by EDGAR at Mar 11, 2019, 07:46 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2018-01-01 to 2018-12-31 | $214.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 12 months2018-01-01 to 2018-12-31 | $114.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2018-01-01 to 2018-12-31 | −$92.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2018-01-01 to 2018-12-31 | $1.0m | us-gaap:InterestExpense |
| Income tax | 12 months2018-01-01 to 2018-12-31 | $4.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2018-01-01 to 2018-12-31 | −$74.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2018-01-01 to 2018-12-31 | −$1.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2018-01-01 to 2018-12-31 | −$1.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2018-01-01 to 2018-12-31 | 66,426,382 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2018-01-01 to 2018-12-31 | −$32.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2018-01-01 to 2018-12-31 | $6.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2018-01-01 to 2018-12-31 | $5.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2018-12-31 | $86.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-12-31 | $370.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-12-31 | $532.1m | us-gaap:Assets |
| Current liabilities | At period end2018-12-31 | $85.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-12-31 | $119.9m | us-gaap:Liabilities |
| Long-term debt | At period end2018-12-31 | $26.7m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2018-12-31 | $389.0m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2018-12-31 | 66,657,745 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001047469-19-001057. Last ingested by Listed: Oct 29, 2026, 06:09 ET. Listed shows no prices and gives no investment advice.